Drug may aid quality of life in early Parkinson’s

Adding a drug called entacapone to standard treatment with levodopa for people with early Parkinson’s disease appears to enhance some aspects of their quality of life, researchers report.

Entacapone, also known as Comtan, slows the breakdown of levodopa and has been shown to help Parkinson’s patients on levodopa with fluctuating symptoms, boosting motor function and increasing “on” time while reducing “off” time.

Dr. C. Warren Olanow of Mount Sinai School of Medicine, New York and colleagues looked at whether the drug would be helpful for people with early Parkinson’s and no motor fluctuations.

As described in the Archives of Neurology, the researchers randomly assigned 750 patients to take entacapone or placebo daily for 26 weeks. The medication was then withdrawn over a two-week period.

At the end of the trial, there was no significant difference seen between the two groups on a standard Parkinson’s disease rating scale.

However, those given entacapone showed improvement in several measures of quality of life, including mobility, activities of daily life, physical functioning and vitality.

The researchers suggest that in relatively mild Parkinson’s disease, although there is no improvement in motor score, entacapone may provide “clinical benefits that are subjective and more apparent to patients than physicians.”

Nevertheless, they conclude, “the value of these quality-of-life benefits remains unclear.”

SOURCE: Archives of Neurology, October 2004.

RELATED STORIES:
Eye test peers into heat-related multiple sclerosis symptoms   Researchers Publish Comparison of MS Treatments   Pesticide Use Increases Risk of Parkinson’s in Men   Levitra effective for ED due to spinal cord injury   Welders show elevated rate of Parkinson symptoms   New Web tool may help predict risk of second stroke   Exercise can aid recovery after brain radiation   Researchers Uncover Role of Gene Linked to Parkinson’s Disease   Scientists Identify How Immune Cells May Help Predict Alzheimer’s Risk   Drinking tea might delay Alzheimer’s disease   Awareness may remain after severe brain injury   High-dose paracetamol “may help stroke patients”

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]